[1]
|
Freemantle, N., Cleland, J., Young, P., et al. (1999) Beta Blockade after Myocardial Infarction: Systematic Review and Meta Regression Analysis. BMJ (Clinical Research ed), 318, 1730-1737. https://doi.org/10.1136/bmj.318.7200.1730
|
[2]
|
Cruickshank, J.M. (2017) The Role of Beta-Blockers in the Treatment of Hypertension. Advances in Experimental Medicine and Biology, 956, 149-166. https://doi.org/10.1007/5584_2016_36
|
[3]
|
Lindholm, L.H., Carlberg, B., Samuelsson, O. (2005) Should Beta Blockers Remain First Choice in the Treatment of Primary Hypertension? A Meta-Analysis. The Lancet (London, England), 366, 1545-1553.
https://doi.org/10.1016/S0140-6736(05)67573-3
|
[4]
|
Antoni, M.H., Lutgendorf, S.K., Cole, S.W., et al. (2006) The Influence of Bio-Behavioural Factors on Tumour Biology: Pathways and Mechanisms. Nature Reviews Cancer, 6, 240-248. https://doi.org/10.1038/nrc1820
|
[5]
|
Ginguerra, M.A., Saito, O., Fernandes, J., et al. (2018) Clinical and Radiological Evaluation of Periocular Infantile Hemangioma Treated with Oral Propranolol: A Case Series. American Journal of Ophthalmology, 185, 48-55.
https://doi.org/10.1016/j.ajo.2017.10.021
|
[6]
|
Li, P., Guo, Z., Gao, Y., et al. (2015) Propranolol Represses Infantile Hemangioma Cell Growth through the Beta2-Adrenergic Receptor in a HIF-1alpha-Dependent Manner. Oncology Reports, 33, 3099-3107.
https://doi.org/10.3892/or.2015.3911
|
[7]
|
刘超, 刘少华, 王丽丽, 等. β肾上腺素受体在婴幼儿血管瘤发病机制中作用的探讨[J]. 口腔医学, 2011, 31(7): 434-5.
|
[8]
|
Yao, H., Duan, Z., Wang, M., et al. (2009) Adrenaline Induces Chemoresistance in HT-29 Colon Adenocarcinoma Cells. Cancer Genetics and Cytogenetics, 190, 81-87. https://doi.org/10.1016/j.cancergencyto.2008.12.009
|
[9]
|
Jobling, P., Pundavela, J., Oliveira, S.M., et al. (2015) Nerve-Cancer Cell Cross-Talk: A Novel Promoter of Tumor Progression. Cancer Research, 75, 1777-1781. https://doi.org/10.1158/0008-5472.CAN-14-3180
|
[10]
|
Zhang, D., Ma, Q.Y., Hu, H.T., et al. (2010) beta2-Adrenergic Antagonists Suppress Pancreatic Cancer Cell Invasion by Inhibiting CREB, NFkappaB and AP-1. Cancer Biology & Therapy, 10, 19-29.
https://doi.org/10.4161/cbt.10.1.11944
|
[11]
|
Chin, C.C., Li, J.M., Lee, K.F., et al. (2016) Selective beta2-AR Blockage Suppresses Colorectal Cancer Growth Through Regulation of EGFR-Akt/ERK1/2 Signaling, G1-Phase Arrest, and Apoptosis. Journal of Cellular Physiology, 231, 459-472. https://doi.org/10.1002/jcp.25092
|
[12]
|
Masur, K., Niggemann, B., Zanker, K.S., et al. (2001) Norepinephrine-Induced Migration of SW 480 Colon Carcinoma Cells Is Inhibited by Beta-Blockers. Cancer Research, 61, 2866-2869.
|
[13]
|
Shan, T., Cui, X., Li, W., et al. (2014) Novel Regulatory Program for Norepinephrine-Induced Epithelial-Mesenchymal Transition in Gastric Adenocarcinoma Cell Lines. Cancer Science, 105, 847-856.
https://doi.org/10.1111/cas.12438
|
[14]
|
Lu, Y.J., Geng, Z.J., Sun, X.Y., et al. (2015) Isoprenaline Induces Epithelial-Mesenchymal Transition in Gastric Cancer Cells. Molecular and Cellular Biochemistry, 408, 1-13. https://doi.org/10.1007/s11010-015-2477-0
|
[15]
|
杨国清. 乳腺癌中β2肾上腺素受体的表达及其与Her-2、K-ras基因的相关性研究[D]: [硕士学位论文]. 苏州: 苏州大学, 2014.
|
[16]
|
Gargiulo, L., May, M., Rivero, E.M., et al. (2017) A Novel Effect of Beta-Adrenergic Receptor on Mammary Branching Morphogenesis and Its Possible Implications in Breast Cancer. Journal of Mammary Gland Biology and Neoplasia, 22, 43-57. https://doi.org/10.1007/s10911-017-9371-1
|
[17]
|
Drell, T.L.T., Joseph, J., Lang, K., et al. (2003) Effects of Neurotransmitters on the Chemokinesis and Chemotaxis of MDA-MB-468 Human Breast Carcinoma Cells. Breast Cancer Research and Treatment, 80, 63-70.
https://doi.org/10.1023/A:1024491219366
|
[18]
|
Draoui, A., Vandewalle, B., Hornez, L., et al. (1991) Beta-Adrenergic Receptors in Human Breast Cancer: Identification, Characterization and Correlation with Progesterone and Estradiol Receptors. Anticancer Research, 11, 677-680.
|
[19]
|
Lang, K., Drell, T.L.T., Lindecke, A., et al. (2004) Induction of a Metastatogenic Tumor Cell Type by Neurotransmitters and Its Pharmacological Inhibition by Established Drugs. International Journal of Cancer, 112, 231-238.
https://doi.org/10.1002/ijc.20410
|
[20]
|
Sastry, K.S., Karpova, Y., Prokopovich, S., et al. (2007) Epinephrine Protects Cancer Cells from Apoptosis via Activation of cAMP-Dependent Protein Kinase and BAD Phosphorylation. The Journal of Biological Chemistry, 282, 14094-14100. https://doi.org/10.1074/jbc.M611370200
|
[21]
|
Slotkin, T.A., Zhang, J., Dancel, R., et al. (2000) Beta-Adrenoceptor Signaling and Its Control of Cell Replication in MDA-MB-231 Human Breast Cancer Cells. Breast Cancer Research and Treatment, 60, 153-166.
https://doi.org/10.1023/A:1006338232150
|
[22]
|
Sorensen, G.V., Ganz, P.A., Cole, S.W., et al. (2013) Use of Beta-Blockers, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Risk of Breast Cancer Recurrence: A Danish Nationwide Prospective Cohort Study. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 31, 2265-2272.
https://doi.org/10.1200/JCO.2012.43.9190
|
[23]
|
Childers, W.K., Hollenbeak, C.S. and Cheriyath, P. (2015) beta-Blockers Reduce Breast Cancer Recurrence and Breast Cancer Death: A Meta-Analysis. Clinical Breast Cancer, 15, 426-431. https://doi.org/10.1016/j.clbc.2015.07.001
|
[24]
|
薛晶. 心理应激对胰腺癌浸润、转移的影响及β2肾上腺素受体的检测[D]: [硕士学位论文]. 青岛: 青岛大学, 2011.
|
[25]
|
Partecke, L.I., Speerforck, S., Kading, A., et al. (2016) Chronic Stress Increases Experimental Pancreatic Cancer Growth, Reduces Survival and Can Be Antagonised by beta-Adrenergic Receptor Blockade. Pancreatology, 16, 423-433. https://doi.org/10.1016/j.pan.2016.03.005
|
[26]
|
Diaz, E.S., Karlan, B.Y., Li, A.J. (2012) Impact of Beta Blockers on Epithelial Ovarian Cancer Survival. Gynecologic Oncology, 127, 375-378. https://doi.org/10.1016/j.ygyno.2012.07.102
|
[27]
|
Grytli, H.H., Fagerland, M.W., Fossa, S.D., et al. (2013) Use of Beta-Blockers Is Associated with Prostate Cancer-Specific Survival in Prostate Cancer Patients on Androgen Deprivation Therapy. The Prostate, 73, 250-260.
https://doi.org/10.1002/pros.22564
|
[28]
|
Palm, D., Lang, K., Niggemann, B., et al. (2006) The Norepinephrine-Driven Metastasis Development of PC-3 Human Prostate Cancer Cells in BALB/c Nude Mice Is Inhibited by β-Blockers. International Journal of Cancer, 118, 2744-2749. https://doi.org/10.1002/ijc.21723
|
[29]
|
Wang, H.M., Liao, Z.X., Komaki, R., et al. (2013) Improved Survival Outcomes with the Incidental Use of Beta-Blockers among Patients with Non-Small-Cell Lung Cancer Treated with Definitive Radiation Therapy. Annals of Oncology, 24, 1312. https://doi.org/10.1093/annonc/mds616
|
[30]
|
Yoshioka, Y., Kadoi, H., Yamamuro, A., et al. (2016) Noradrenaline Increases Intracellular Glutathione in Human Astrocytoma U-251 MG Cells by Inducing Glutamate-Cysteine Ligase Protein via β3-Adrenoceptor Stimulation. European Journal of Pharmacology, 772, 51-61. https://doi.org/10.1016/j.ejphar.2015.12.041
|
[31]
|
Hanoun, M., Zhang, D., Mizoguchi, T., et al. (2014) Acute Myelogenous Leukemia-Induced Sympathetic Neuropathy Promotes Malignancy in an Altered Hematopoietic Stem Cell Niche. Cell Stem Cell, 15, 365-375.
https://doi.org/10.1016/j.stem.2014.06.020
|
[32]
|
Lamkin, D.M., Sloan, E.K., Patel, A.J., et al. (2012) Chronic Stress Enhances Progression of Acute Lymphoblastic Leukemia via β-Adrenergic Signaling. Brain Behavior & Immunity, 26, 635-641.
https://doi.org/10.1016/j.bbi.2012.01.013
|
[33]
|
李婷, 郭鹏翔, 雷霆雯, 等. 噻吗洛尔对人多发性骨髓瘤细胞株 RPMI 8226增殖、凋亡的影响及其机制[J]. 山东医药, 2016, 56(27): 24-27.
|
[34]
|
刘扬. β肾上腺素能受体通路对多发性骨髓瘤细胞的体外作用研究[D]: [博士学位论文]. 北京: 北京协和医学院, 2014.
|
[35]
|
Nissen, M.D., Sloan, E.K. and Mattarollo, S.R. (2017) Beta-Adrenergic Signaling Impairs Anti-Tumor CD8+ T Cell Responses to B Cell Lymphoma Immunotherapy. Cancer Immunology Research, 6, 98-109.
https://doi.org/10.1158/2326-6066.CIR-17-0401
|
[36]
|
李婷, 郭鹏翔, 王季石. β肾上腺素能受体在肿瘤中的研究进展[J]. 医学综述, 2016, 22(13): 2557-2560.
|